Financials data is unavailable for this security.
View more
Year on year Tandem Diabetes Care Inc grew revenues 25.74% from 747.72m to 940.20m while net income improved from a loss of 222.61m to a smaller loss of 96.03m.
Gross margin | 52.07% |
---|---|
Net profit margin | -10.21% |
Operating margin | -10.68% |
Return on assets | -10.00% |
---|---|
Return on equity | -33.30% |
Return on investment | -12.99% |
More ▼
Cash flow in USDView more
In 2024, Tandem Diabetes Care Inc increased its cash reserves by 17.61%, or 10.37m. The company earned 24.23m from its operations for a Cash Flow Margin of 2.58%. In addition the company generated 8.37m cash from financing while 23.48m was spent on investing.
Cash flow per share | -1.21 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.97 |
---|---|
Tangible book value per share | 3.96 |
More ▼
Balance sheet in USDView more
Current ratio | 2.93 |
---|---|
Quick ratio | 2.33 |
Total debt/total equity | 1.33 |
---|---|
Total debt/total capital | 0.5701 |
More ▼